midazolam and docetaxel anhydrous

midazolam has been researched along with docetaxel anhydrous in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (36.36)	29.6817
2010's	7 (63.64)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Fan, L; Goh, BC; Guo, JY; Lamba, J; Lee, HS; Lee, SC; Lim, HL; Lim, R; Ong, AB; Schuetz, E; Wang, LZ	1
Fan, L; Goh, BC; Lee, HS; Lee, SC; Ong, AB; Soo, R; Sukri, N; Tham, LS; Wang, L; Yong, WP	1
Alexandre, J; Dieras, V; Girre, V; Goldwasser, F; Grabar, S; Hérait, P; Jullien, V; Montheil, V; Pons, G; Rabillon, F; Rey, E; Tran, A; Treluyer, JM	1
Goh, BC; Lee, HS; Lee, SC; Soo, R; Sukri, N; Tham, LS; Wang, LZ; Wong, CI; Yong, WP	1
Hilli, J; Jyrkkiö, S; Laine, K; Pyrhönen, S; Sailas, L	1
Aohara, F; Fujimura, Y; Harakawa, N; Hasegawa, R; Katori, N; Kim, SR; Maekawa, K; Naito, M; Niwa, T; Okuda, H; Sai, K; Saito, Y; Sawada, J; Tohkin, M; Yoshimura, T	1
Chen, X; Deng, S; Fan, A; Gao, W; Li, C; Li, N; Liu, Q; Wang, C; Wen, X; Zhang, Q; Zhang, W; Zhang, Y; Zhao, D; Zhao, J	1
Bank, PC; Beijnen, JH; Hendrikx, JJ; Maas-Bakker, RF; Meijerman, I; Mooiman, KD; Rosing, H; Schellens, JH	1
Boggs, JW; Choo, EF; Deng, Y; Hop, CE; McNamara, E; Messick, K; West, K	1

Reviews

1 review(s) available for midazolam and docetaxel anhydrous

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

3 trial(s) available for midazolam and docetaxel anhydrous

Article	Year
Ketoconazole renders poor CYP3A phenotype status with midazolam as probe drug. Therapeutic drug monitoring, 2006, Volume: 28, Issue:2 Topics: Administration, Oral; Anesthetics, Intravenous; Antifungal Agents; Antineoplastic Agents, Phytogenic; Area Under Curve; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Docetaxel; Female; Half-Life; Humans; Infusions, Intravenous; Isoenzymes; Ketoconazole; Male; Metabolic Clearance Rate; Midazolam; Middle Aged; Taxoids	2006
A phase I study of docetaxel with ketoconazole modulation in patients with advanced cancers. Cancer chemotherapy and pharmacology, 2008, Volume: 62, Issue:2 Topics: Antineoplastic Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Docetaxel; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Ketoconazole; Male; Maximum Tolerated Dose; Midazolam; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms; Neutropenia; Taxoids	2008
NCT01110291: induction of CYP3A activity and lowered exposure to docetaxel in patients with primary breast cancer. Cancer chemotherapy and pharmacology, 2011, Volume: 67, Issue:6 Topics: Administration, Oral; Adult; Antineoplastic Agents; Area Under Curve; Breast Neoplasms; Cytochrome P-450 CYP3A; Dexamethasone; Docetaxel; Female; Glucocorticoids; Humans; Midazolam; Middle Aged; Survival Analysis; Taxoids	2011

Other Studies

7 other study(ies) available for midazolam and docetaxel anhydrous

Article	Year
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Explaining interindividual variability of docetaxel pharmacokinetics and pharmacodynamics in Asians through phenotyping and genotyping strategies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Sep-01, Volume: 20, Issue:17 Topics: Adult; Aged; Analysis of Variance; Antineoplastic Agents, Phytogenic; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Docetaxel; Ethnicity; Female; Genes, MDR; Genotype; Humans; Linear Models; Male; Metabolic Clearance Rate; Midazolam; Middle Aged; Multivariate Analysis; Oxidoreductases, N-Demethylating; Paclitaxel; Phenotype; Polymorphism, Genetic; Taxoids	2002
Relationship between cytochrome 3A activity, inflammatory status and the risk of docetaxel-induced febrile neutropenia: a prospective study. Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:1 Topics: Aged; Antineoplastic Agents; Area Under Curve; Cytochrome P-450 CYP3A; Docetaxel; Female; Ferritins; Humans; Lymphocyte Count; Male; Midazolam; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Radiation-Sensitizing Agents; Risk Factors; Taxoids	2007
CYP3A416 and CYP3A418 alleles found in East Asians exhibit differential catalytic activities for seven CYP3A4 substrate drugs. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Alleles; Animals; Asia, Eastern; Atorvastatin; Biocatalysis; Camptothecin; Carbamazepine; Cytochrome P-450 CYP3A; Docetaxel; Heptanoic Acids; Humans; Irinotecan; Midazolam; Models, Molecular; Paclitaxel; Pyrroles; Spodoptera; Substrate Specificity; Taxoids; Terfenadine	2010
Effect of triacontanol on the pharmacokinetics of docetaxel in rats associated with induction of cytochrome P450 3A1/2. Xenobiotica; the fate of foreign compounds in biological systems, 2014, Volume: 44, Issue:7 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Cytochrome P-450 CYP3A; Docetaxel; Enzyme Induction; Fatty Alcohols; Female; Gene Expression Regulation, Enzymologic; Male; Microsomes, Liver; Midazolam; Rats, Sprague-Dawley; Reproducibility of Results; Taxoids	2014
The effect of complementary and alternative medicines on CYP3A4-mediated metabolism of three different substrates: 7-benzyloxy-4-trifluoromethyl-coumarin, midazolam and docetaxel. The Journal of pharmacy and pharmacology, 2014, Volume: 66, Issue:6 Topics: Complementary Therapies; Coumarins; Cytochrome P-450 CYP3A; Docetaxel; Ginkgo biloba; Grape Seed Extract; Humans; Microsomes, Liver; Midazolam; Silybum marianum; Taxoids; Tea	2014
Assessment of the hepatic CYP reductase null mouse model and its potential application in drug discovery. Molecular pharmaceutics, 2014, Mar-03, Volume: 11, Issue:3 Topics: Animals; Antineoplastic Agents; Cytochrome P-450 Enzyme System; Docetaxel; Drug Discovery; Female; Fibrosarcoma; Hypnotics and Sedatives; Liver; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Midazolam; NADPH-Ferrihemoprotein Reductase; Taxoids; Theophylline; Vasodilator Agents	2014